Barclays’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$886K Buy
10,871
+5,602
+106% +$394K ﹤0.01% 2856
2026
Q1
$300K Sell
5,269
-32,880
-86% -$1.91M ﹤0.01% 3473
2025
Q4
$1.93M Buy
38,149
+3,899
+11% +$199K ﹤0.01% 2955
2025
Q3
$1.71M Sell
34,250
-12,061
-26% -$553K ﹤0.01% 2991
2025
Q2
$1.85M Buy
46,311
+14,726
+47% +$549K ﹤0.01% 2903
2025
Q1
$1.11M Sell
31,585
-12,808
-29% -$505K ﹤0.01% 3045
2024
Q4
$1.74M Buy
44,393
+1,760
+4% +$63.3K ﹤0.01% 2991
2024
Q3
$1.25M Buy
42,633
+17,017
+66% +$519K ﹤0.01% 3206
2024
Q2
$791K Sell
25,616
-8,106
-24% -$257K ﹤0.01% 2744
2024
Q1
$1.21M Sell
33,722
-12,721
-27% -$459K ﹤0.01% 2968
2023
Q4
$1.81M Buy
46,443
+33,033
+246% +$1.07M ﹤0.01% 2993
2023
Q3
$354K Sell
13,410
-2,130
-14% -$64.3K ﹤0.01% 2992
2023
Q2
$543K Sell
15,540
-2,155
-12% -$68.7K ﹤0.01% 2703
2023
Q1
$587K Buy
17,695
+4,486
+34% +$139K ﹤0.01% 3157
2022
Q4
$337K Sell
13,209
-7,543
-36% -$224K ﹤0.01% 3551
2022
Q3
$756K Buy
20,752
+4,324
+26% +$187K ﹤0.01% 2423
2022
Q2
$786K Sell
16,428
-10,287
-39% -$477K ﹤0.01% 2538
2022
Q1
$1.41M Sell
26,715
-15,556
-37% -$818K ﹤0.01% 2147
2021
Q4
$2.17M Buy
42,271
+13,685
+48% +$807K ﹤0.01% 2336
2021
Q3
$1.9M Buy
28,586
+9,770
+52% +$763K ﹤0.01% 2395
2021
Q2
$1.73M Sell
18,816
-15,259
-45% -$1.5M ﹤0.01% 2284
2021
Q1
$4.15M Sell
34,075
-8,438
-20% -$1.4M ﹤0.01% 1680
2020
Q4
$6.52M Sell
42,513
-3,125
-7% -$441K ﹤0.01% 1367
2020
Q3
$5.91M Buy
45,638
+3,507
+8% +$461K ﹤0.01% 1306
2020
Q2
$4.74M Sell
42,131
-922
-2% -$94.6K ﹤0.01% 1413
2020
Q1
$3.28M Sell
43,053
-5,358
-11% -$497K ﹤0.01% 1844
2019
Q4
$4.92M Buy
48,411
+13,814
+40% +$1.37M ﹤0.01% 2018
2019
Q3
$3.53M Sell
34,597
-2,613
-7% -$266K ﹤0.01% 2200
2019
Q2
$4.32M Buy
37,210
+11,194
+43% +$1.2M ﹤0.01% 2009
2019
Q1
$2.73M Buy
26,016
+10,093
+63% +$1.13M ﹤0.01% 2240
2018
Q4
$1.8M Sell
15,923
-20,335
-56% -$2.51M ﹤0.01% 2514
2018
Q3
$5.87M Buy
36,258
+26,691
+279% +$3.78M ﹤0.01% 1654
2018
Q2
$1.14M Sell
9,567
-7,020
-42% -$860K ﹤0.01% 3141
2018
Q1
$1.95M Buy
16,587
+12,651
+321% +$1.43M ﹤0.01% 2488
2017
Q4
$405K Buy
3,936
+3,361
+585% +$302K ﹤0.01% 4067
2017
Q3
$46K Sell
575
-2,481
-81% -$179K ﹤0.01% 5391
2017
Q2
$206K Buy
3,056
+1,835
+150% +$111K ﹤0.01% 4333
2017
Q1
$62K Buy
1,221
+794
+186% +$42K ﹤0.01% 5206
2016
Q4
$22K Sell
427
-84
-16% -$4.4K ﹤0.01% 5583
2016
Q3
$30K Buy
511
+495
+3,094% +$28.5K ﹤0.01% 5269
2016
Q2
$1K Sell
16
-11,920
-100% -$796K ﹤0.01% 6142
2016
Q1
$919K Buy
+11,936
New +$771K ﹤0.01% 2591
2015
Q4
Sell
-317
Closed -$21K 6454
2015
Q3
$21K Sell
317
-254
-44% -$18.1K ﹤0.01% 5444
2015
Q2
$38K Sell
571
-7,611
-93% -$537K ﹤0.01% 5318
2015
Q1
$573K Sell
8,182
-1,560
-16% -$106K ﹤0.01% 3488
2014
Q4
$653K Buy
9,742
+8,484
+674% +$558K ﹤0.01% 3597
2014
Q3
$87K Sell
1,258
-1,569
-56% -$123K ﹤0.01% 5432
2014
Q2
$229K Buy
2,827
+2,112
+295% +$143K ﹤0.01% 4699
2014
Q1
$48K Buy
715
+306
+75% +$22.8K ﹤0.01% 6031
2013
Q4
$29K Sell
409
-3,705
-90% -$287K ﹤0.01% 6514
2013
Q3
$312K Buy
4,114
+3,221
+361% +$223K ﹤0.01% 4596
2013
Q2
$58K Buy
+893
New +$48K ﹤0.01% 6211

Other funds holding PRLB

Barclays's PRLB Position: Q2 2026 in Review

Barclays increased its Protolabs (PRLB) stake by 106% in Q2 2026, buying an estimated $394K and bringing the position to 10,871 shares worth $886K. The position accounts for ﹤0.01% of the portfolio, ranked #2856.

Barclays first reported a position in PRLB in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.52M in Q4 2020. 277 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

  • Barclays held 10,871 shares of Protolabs worth $886K as of Q2 2026.
  • Barclays bought 5,602 Protolabs shares in Q2 2026, an estimated $394K.
  • Protolabs made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2856 holding.
  • Barclays first reported a position in Protolabs in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Protolabs position peaked at $6.52M in Q4 2020.
  • 277 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.